PubMed Health⌕ Search

PubMed · 6696649

Familial systemic carnitine deficiency.

Abstract

Two sisters with systemic carnitine deficiency showed the heterogenicity of this condition and a lack of correlation between measurable carnitine levels and clinical manifestations. One child experienced recurrent metabolic encephalopathy, which was diagnosed as Reye's syndrome. The older child, despite lower carnitine concentrations, was asymptomatic. Lipid inclusion myopathy was shown in both children. Serum, muscle, and liver carnitine levels were reduced. The parents had normal serum carnitine concentrations. Both children had significantly abnormal renal handling of carnitine, and their mother, a mild alteration. This family provided evidence for genetic transmission and presumed autosomal recessive inheritance in this disease. Both children were treated with carnitine without clear benefit; no side effects were noted. Previously reported cases of systemic carnitine deficiency were reviewed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R P Cruse, S Di Mauro, J Towfighi, C Trevisan. 1984. Familial systemic carnitine deficiency.. https://doi.org/10.1001/archneur.1984.04050150079021

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A magnetic resonance approach to metabolic disorders in childhood.

INTRODUCTION: Inborn errors of metabolism are a difficult group of disorders to diagnose. Clinical signs and symptoms overlap among the different diseases, biochemical tests are often nonspecific or unrevealing, and genetic analyses are time consuming, expensive, and often not commercially available. Imaging can aid in diagnosing some disorders, but the imaging findings of many disorders seem to overlap, particularly as more and more disorders are identified and described. DEVELOPMENT: Several groups have proposed an imaging approach based upon pattern recognition on magnetic resonance imaging, supplemented by metabolic data from proton magnetic resonance spectroscopy and microstructural data, as assessed by diffusion weighted imaging. CONCLUSION: When properly used, this pattern recognition approach in conjunction with the other imaging tools can be very useful for separating the complex group of metabolic disorders into more manageable groups. Indeed, sometimes this approach allows a specific diagnosis to be made.

Brain Diseases, Metabolic↗

Stable neuropsychological deficits in adult polyglucosan body disease.

We describe a 61-year-old woman who gradually developed deficits of balance, gait, and the ability to negotiate movement in space, together with an unusual pattern of cognitive deficits. A series of non-invasive investigations over three years including EEG, CT, MRI, PET and serial neuropsychological review had not provided a diagnosis. Significantly, the four neuropsychological assessments had revealed no progressive decline in cognition. Brain biopsy revealed an abundance of corpora amylacea, and a diagnosis of adult polyglucosan body disease (APBD) was made. This case contributes to the body of knowledge about the cognitive manifestations of this rare disease, and the stability of its functional impact over time.

Brain Diseases, Metabolic↗